DIA
ACAD icon

Dana Investment Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Dana Investment Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23,363
Closed -$603K – 317
2021
Q1 		$603K Buy
23,363
+2,093
+10% +$92.1K 0.03% 238
2020
Q4 		$1.14M Buy
21,270
+3,464
+19% +$172K 0.06% 203
2020
Q3 		$734K Sell
17,806
-20,182
-53% -$872K 0.04% 213
2020
Q2 		$1.84M Buy
+37,988
New +$1.82M 0.1% 120

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dana Investment Advisors's ACAD Position: Q2 2021 in Review

Dana Investment Advisors sold out of Acadia Pharmaceuticals (ACAD) in Q2 2021, closing a stake of 23,363 shares — an estimated $603K sold.

Dana Investment Advisors first reported a position in ACAD in Q2 2020 and held it in 4 quarters. The position peaked at $1.84M in Q2 2020. 245 funds tracked by Wall St. Rank hold ACAD as of Q2 2021.

  • Dana Investment Advisors reported no remaining Acadia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Dana Investment Advisors sold 23,363 Acadia Pharmaceuticals shares in Q2 2021, an estimated $603K.
  • Dana Investment Advisors first reported a position in Acadia Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Dana Investment Advisors's Acadia Pharmaceuticals position peaked at $1.84M in Q2 2020.
  • 245 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2021.

Based on Dana Investment Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.